British Business Bank β 2026 Investments
10 investments dated 2026 Β· listed companies and verified rows first Β· show all
Ineffable is an AI research lab focused on building superintelligence through the reinforcement learning paradigm, emphasizing learning from experience in the environment rather than from human data.
AI & Machine LearningDeep TechLondon, GB
David Silver(Founder)inAlexandre Laterre(Co-Founder)inChris Apps(Founder)in
BoardAlfred Lin(Director (Sequoia Capital))Ravi Mhatre(Director (Lightspeed))
Co-investorsEQT VenturesFlying Fish VenturesIndex VenturesLightspeed Venture PartnersSequoia CapitalBond Capital Management+6 more
Alchemab operates a platform that identifies novel drug targets and therapeutics by analyzing patient antibody repertoires using deep B cell sequencing and computational analysis of samples from disease-resilient individuals.
AI & Machine LearningBiotechDeep TechHealthtech
Jane Osbourn(Chief Executive Officer)
Co-investorsSV Health InvestorsDCVC BioRA CapitalDementia Discovery FundLightstone VenturesOno Venture Investment, Inc.+2 more
Draig develops neuropsychiatric therapies targeting glutamate and GABA pathways through AMPA and GABAA receptor modulators, serving patients with neuropsychiatric disorders.
BiotechDeep TechDigital HealthMedical DevicesCardiff, GB
John Atack(Head of Biology & Founder)inSimon Ward(Chief Scientific Officer & Founder)in
Co-investorsAccess BiotechnologyCanaan PartnersSanofi VenturesSV Health InvestorsSR One Capital ManagementJanus Henderson Investors
Elliptic provides blockchain forensics and compliance investigation tools that help financial institutions trace cryptocurrency transactions across multiple networks and assets to detect illicit activity and generate regulatory reports.
Crypto & Web3Enterprise SoftwareFintechLondon
James Smith(Executive Officer, Director)Adam Joyce(Executive Officer)inTom Robinson(Founder)inSimone Mainiin
BoardEyal Rabinovich(Director)Walter Kortschak(Director)
Co-investorsAlbionVCDigital Currency GroupEvolution Equity PartnersMiddlegame VenturesMouro CapitalOctopus Ventures+11 more
Neuronostics develops BioEP, software that applies digital analysis of background EEG to generate biomarkers supporting epilepsy diagnosis for clinicians and neurology services.
AI & Machine LearningDigital HealthMedical Devices
John Terry(Founder)in
Co-investorsNew Wave VenturesThe FSE GroupAscension VenturesEmpirical VenturesInnovate UK
Oxbury is a fully regulated bank dedicated exclusively to serving the UK rural economy and farmers, offering long-term loans, mortgages, and cashflow products.
AgTechFintechImpact & Social GoodUK, GB
Co-investorsSalica Investments
Proof is an approvals platform that helps government agencies digitize forms, implement electronic signatures, and manage approvals in a central software system.
GovTechWhitehorse, CA
Co-investorsConcrete VenturesTechstarsPanache Ventures
Stream provides infrastructure for building AI applications and real-time communication features including chat, video, feed, and moderation across multiple platforms.
AI & Machine LearningCloud ComputingData & InfrastructureDeveloper ToolsEnterprise SoftwareBoulder, US
Thierry Schellenbach(Founder)in
Co-investorsTechstarsFelicis VenturesSocial StartsUpslope VenturesUpVentures CapitalV1 VC+5 more
Stream provides AI-powered claims management software for property and casualty insurers, using machine learning to detect inconsistencies and optimize claim outcomes across the entire claim lifecycle.
AI & Machine LearningFintechInsurTechSaaSSan Francisco, US
Eilam Levitov(Founder)in
Co-investorsIA Seed VenturesY CombinatorAscension VenturesNorthzoneSmash CapitalSofina
Tembo builds a platform that serves as an operating layer for software engineering teams, providing secure execution, shared context, and workflow coordination for AI coding agents.
AI & Machine LearningCloud ComputingDeveloper ToolsEnterprise Software
Co-investorsGreatPoint VenturesCincyTechCintrifuse CapitalGrand VenturesWireframe VenturesAscension+4 more
Rows marked βSEC filingβ are inferred from directors named on the company's SEC Form D β public regulatory data, not a portfolio list published by the firm.